Loratadine/Nortriptyline Hydrochloride

氯雷他定/盐酸去甲替林

Report date: 2022/11/25 17:01:03

Base Information

Drug NameLoratadine/Nortriptyline Hydrochloride
Drug Alias NameNortriptyline and Loratadine氯雷他定盐酸去甲替林去甲替林/氯雷他定nortriptyline HCl/loratadine氯雷他定去甲替林 +[10] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsMonoamine oxidase inhibitors
TargetsMonoamine oxidaseHistamine H1 receptor
Therapy Area/IndicationsPlaque psoriasisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsYes LoratadineNortriptyline Hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZalicus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZalicus Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A